U.S. Markets closed

OPKO Diagnostics, Sony DADC announce manufacturing partnership

OPKO Diagnostics, a division of OPKO Health (OPK), and Sony DADC announced the signing of a supply agreement for high volume production of a key component of the OPKO Sangia microfluidic cassette. The Sangia cassettes are designed to perform quantitative immunoassays from a finger-stick blood sample on the Claros1 in-office analyzer. The test results are reported in the physician’s office in 10 minutes. The first two OPKO Sangia tests are for total prostate specific antigen and Total Testosterone.